Recent developments on triazole nucleus in anticonvulsant compounds: a review

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Drug Discovery

Background:

• Epilepsy affects over 50 million people globally, with current anticonvulsant treatments facing limitations due to side effects, intolerance, and variable efficacy.
• The development of novel anticonvulsant agents with improved efficacy and safety profiles remains a critical challenge in medicinal chemistry.
• Triazole derivatives have demonstrated significant therapeutic potential across various diseases, highlighting their importance as a privileged scaffold in drug design.

Purpose of the Study:

• To systematically review the research on triazole derivatives in the design and development of anticonvulsant agents.
• To consolidate recent advancements in utilizing the triazole nucleus for creating novel epilepsy treatments.
• To provide an overview of the past two decades of research in this specialized area of medicinal chemistry.

Main Methods:

• Systematic literature review of scientific publications and patents.
• Analysis of research focusing on triazole derivatives as potential anticonvulsant agents.
• Examination of studies reporting efficacy, toxicity, and structure-activity relationships.

Main Results:

• Numerous triazole derivatives have been investigated for anticonvulsant properties.
• The triazole scaffold has been successfully incorporated into the design of various active anticonvulsant compounds.
• Research indicates a growing trend in exploring triazole-based compounds for epilepsy treatment.

Conclusions:

• Triazole derivatives represent a promising class of compounds for the development of next-generation anticonvulsant therapies.
• Continued research into triazole chemistry holds potential for discovering agents with enhanced efficacy and reduced toxicity for epilepsy management.
• The systematic review underscores the significant contribution of triazole derivatives to the field of anticonvulsant drug discovery.